Learn more at LeadIQ.com

Insights

Strategic Partnerships REGENXBIO Inc. has established a partnership with Botox® and is collaborating with AbbVie on ABBV-RGX-314 for retinal diseases. This provides opportunities for cross-selling and expanding product offerings.

Investment Opportunities Recent investments by Perceptive Advisors, LLC of $6.15 million showcase investor confidence in REGENXBIO Inc.'s potential, presenting opportunities for financial partnerships or stakeholder engagements.

Top Talent Acquisition With key hires like Mitchell Chan as CFO and executives in technology and operations roles, REGENXBIO Inc. is bolstering its leadership team, indicating possible collaborations or partnerships with other organizations through networking.

Funding Success Having raised $140 million in public financing indicates financial stability and growth prospects for REGENXBIO Inc. This could signify potential areas for investment or joint ventures.

Transition in Leadership With leadership changes, such as Kenneth Mills stepping down as CEO, there might be opportunities for new business models, product innovation, or strategic alliances under fresh leadership in REGENXBIO Inc.

Similar companies to REGENXBIO

Passage Bio
84$10M$50M

REGENXBIO Tech Stack

REGENXBIO uses 8 technology products and services including MySQL, Microsoft Excel, Linux, and more. Explore REGENXBIO's tech stack below.

MySQL
Database
Microsoft Excel
Editors
Linux
Programming Languages
PHP
Programming Languages
Smartsheet
Project Management
Akamai Web Application Protector
Security
Bootstrap
UI Frameworks
Gravity Forms
Web Platform Extensions

Media & News

REGENXBIO's Email Address Formats

REGENXBIO uses at least 1 format(s):

REGENXBIO Email Formats	Example	Percentage
FLast@regenxbio.com	JDoe@regenxbio.com	94%
Last@regenxbio.com	Doe@regenxbio.com	4%
FirstLast@regenxbio.com	JohnDoe@regenxbio.com	1%
FMiddleLast@regenxbio.com	JMichaelDoe@regenxbio.com	1%

Frequently Asked Questions

Where is REGENXBIO's headquarters located?

REGENXBIO's main headquarters is located at 9804 Medical Center Dr Rockville, Maryland 20850 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is REGENXBIO's phone number?

You can contact REGENXBIO's main corporate office by phone at

+1-202-785-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is REGENXBIO's stock symbol?

REGENXBIO is a publicly traded company; the company's stock symbol is RGNX.

What is REGENXBIO's official website and social media links?

REGENXBIO's official website is regenxbio.com and has social profiles on LinkedIn.

How much revenue does REGENXBIO generate?

As of November 2024, REGENXBIO's annual revenue reached $75M.

What is REGENXBIO's SIC code NAICS code?

REGENXBIO's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does REGENXBIO have currently?

As of November 2024, REGENXBIO has approximately 360 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Scientific Officer: O. D.Chief Medical Officer: S. P.Chief Communications & People Officer: S. F.. Explore REGENXBIO's employee directory with LeadIQ.

What industry does REGENXBIO belong to?

REGENXBIO operates in the Biotechnology Research industry.

What technology does REGENXBIO use?

REGENXBIO's tech stack includes MySQLMicrosoft ExcelLinuxPHPSmartsheetAkamai Web Application ProtectorBootstrapGravity Forms.

What is REGENXBIO's email format?

REGENXBIO's email format typically follows the pattern of . Find more REGENXBIO email formats with LeadIQ.

How much funding has REGENXBIO raised to date?

As of November 2024, REGENXBIO has raised $140M in funding. The last funding round occurred on Mar 06, 2024 for $140M.

When was REGENXBIO founded?

REGENXBIO was founded in 2008.

REGENXBIO

REGENXBIO

Biotechnology ResearchMaryland, United States201-500 Employees

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.

Company Overview

Headquarters: 9804 Medical Center Dr Rockville, Maryland 20850 US
Phone number: ✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-202-785-****
Website: regenxbio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: RGNX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2008
Employees: 201-500

Media & News

Funding & Financials

$140M
REGENXBIO has raised a total of $140M of funding over 10 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $140M.
$50M$100M
REGENXBIO's revenue is in the range of $50M$100M

Funding & Financials

$140M
REGENXBIO has raised a total of $140M of funding over 10 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $140M.
$50M$100M
REGENXBIO's revenue is in the range of $50M$100M

Company Leadership

O. D.
Chief Scientific Officer
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. P.
Chief Medical Officer
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. F.
Chief Communications & People Officer
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. R.
Chief Medical Officer
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. F.
Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

S. F.
Chief Communications & People Officer
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. R.
Manager Office Of The Chief Executive Officer
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. R.
Chief Medical Officer
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
X. Z.
President
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. P.
Executive Vice President
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO and Millions of Other Companies
Sign up for full access to REGENXBIO information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.